drugset / Trial / NCT00336154

Study to Evaluate the Efficacy of Tetracycline in Epidermolysis Bullosa

NCT00336154

Phase 4 Withdrawn Rambam Health Care Campus
RandomizedCrossoverDouble-blindTreatment

Summary

Epidermolysis Bullosa(EB) is an inherited bullous disease. Tetracycline is believed to have anti inflammatory properties. 20 patients with EB older than 13 years will be treated for 4 months with tetracycline or placebo. After one month of wash out they will be treated for additional 4 m with placebo or tetracycline. The patients will be examined each month to estimate bulla formation,rate of healing .

Timeline

Start
Primary completion
2006-06
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject tetracyclin Unknown

Indications